KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lam Research (LRCX) EBITDA (2016 - 2026)

Lam Research has reported EBITDA over the past 18 years, most recently at $2.0 billion for Q1 2026.

  • For Q1 2026, EBITDA rose 31.07% year-over-year to $2.0 billion; the TTM value through Mar 2026 reached $7.4 billion, up 40.5%, while the annual FY2025 figure was $5.9 billion, 38.39% up from the prior year.
  • EBITDA for Q1 2026 was $2.0 billion at Lam Research, up from $1.8 billion in the prior quarter.
  • Over five years, EBITDA peaked at $2.0 billion in Q1 2026 and troughed at $854.6 million in Q2 2023.
  • A 5-year average of $1.4 billion and a median of $1.3 billion in 2024 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 42.23% in 2023 and later surged 54.55% in 2025.
  • Year by year, EBITDA stood at $1.7 billion in 2022, then crashed by 37.08% to $1.1 billion in 2023, then grew by 26.17% to $1.3 billion in 2024, then surged by 35.71% to $1.8 billion in 2025, then increased by 13.08% to $2.0 billion in 2026.
  • Business Quant data shows EBITDA for LRCX at $2.0 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.